ES2187457T3 - Procedimiento para la obtencion de formas de dosificacion solidas que contienen ciclodextrina. - Google Patents

Procedimiento para la obtencion de formas de dosificacion solidas que contienen ciclodextrina.

Info

Publication number
ES2187457T3
ES2187457T3 ES00916925T ES00916925T ES2187457T3 ES 2187457 T3 ES2187457 T3 ES 2187457T3 ES 00916925 T ES00916925 T ES 00916925T ES 00916925 T ES00916925 T ES 00916925T ES 2187457 T3 ES2187457 T3 ES 2187457T3
Authority
ES
Spain
Prior art keywords
dosage forms
solid dosage
forms containing
procedure
obtaining solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00916925T
Other languages
English (en)
Inventor
Gunther Berndl
Ulrich Reinhold
Dirk Simon
Stephan Lehmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2187457T3 publication Critical patent/ES2187457T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A01N25/10—Macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Procedimiento para la obtención de formas de dosificación sólidas para la administración oral o rectal en hombre y animal, mezclándose y plastificándose a) un 0, 5 a un 30 % en peso de al menos un principio activo, b) un 0, 5 a un 70 % en peso de al menos una ciclodextrina, c) un 10 a un 98 % en peso de al menos un agente aglutinante polímero, que es seleccionado entre polietilenglicol con un peso molecular por encima de 1.000, polivinilpirrolidona o copolímeros que contienen N-vinilpirrolidona y acetato de vinilo, d) un 0 a un 50 % en peso de substancias auxiliares habituales a una temperatura por debajo de 220°C sin adición de un disolvente, y moldeándose la mezcla plástica obtenida para dar la forma de dosificación.
ES00916925T 1999-03-12 2000-03-10 Procedimiento para la obtencion de formas de dosificacion solidas que contienen ciclodextrina. Expired - Lifetime ES2187457T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19911097A DE19911097A1 (de) 1999-03-12 1999-03-12 Verfahren zur Herstellung von festen cyclodextrinhaltigen Dosierungsformen

Publications (1)

Publication Number Publication Date
ES2187457T3 true ES2187457T3 (es) 2003-06-16

Family

ID=7900771

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00916925T Expired - Lifetime ES2187457T3 (es) 1999-03-12 2000-03-10 Procedimiento para la obtencion de formas de dosificacion solidas que contienen ciclodextrina.

Country Status (10)

Country Link
EP (1) EP1158962B1 (es)
JP (1) JP4861552B2 (es)
AT (1) ATE228828T1 (es)
BR (1) BR0008872B1 (es)
CA (1) CA2367020C (es)
DE (2) DE19911097A1 (es)
DK (1) DK1158962T3 (es)
ES (1) ES2187457T3 (es)
PT (1) PT1158962E (es)
WO (1) WO2000054751A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006089993A2 (es) 2005-02-25 2006-08-31 Universidade De Santiago De Compostela Procedimiento de obtención de hidrogeles de ciclodextrinas con glicidiléteres, las composiciones obtenidas y sus aplicaciones

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175205B1 (en) 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
SI1278549T1 (sl) 2000-05-02 2009-04-30 Theravance Inc Sestavek, ki vsebuje ciklodekstrin in glikopeptidni antibiotik
AU2001259298A1 (en) 2000-05-02 2001-11-12 Advanced Medicine, Inc. Polyacid glycopeptide derivatives
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US6828299B2 (en) 2000-06-22 2004-12-07 Theravance, Inc. Polyhydroxy glycopeptide derivatives
US6872804B2 (en) 2000-06-22 2005-03-29 Theravance, Inc. Glycopeptide disulfide and thioester derivatives
ES2302733T3 (es) 2000-06-22 2008-08-01 Theravance, Inc. Derivados carboxi-sacaridos de glucopeptido.
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
FR2828380B1 (fr) * 2001-08-10 2005-07-29 Fontarome Composition a structure composite contenant des substances aromatiques et/ou des substances non aromatiques volatiles et/ou sensibles aux agents exterieurs, et son procede de fabrication
DE10141682A1 (de) * 2001-08-25 2003-03-06 Beiersdorf Ag Verwendung von Cyclodextrinen zur Herstellung kosmetischer und dermatologischer Zubereitungen mit verbesserter Verteilbarkeit von Füllstoffen auf der Haut sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an Cyclodextrinen und Füllstoffen
DE10157350A1 (de) * 2001-11-22 2003-05-28 Stockhausen Chem Fab Gmbh Herstellung von Wirkstoffzusammensetzung durch Extrudieren von wasserabsorbierenden Polymeren
US7001893B2 (en) * 2002-10-28 2006-02-21 Council Of Scientific And Industrial Research Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US7955630B2 (en) * 2004-09-30 2011-06-07 Kraft Foods Global Brands Llc Thermally stable, high tensile strength encapsulated actives
CN108883125B (zh) * 2016-02-04 2022-08-09 西泽普研究与发展有限责任公司 受控释放和层状的环糊精包合物媒介物
DE102016014603A1 (de) 2016-06-30 2018-01-04 Thomas Herkenroth Synthetisches Ayahuasca
WO2020213010A1 (en) * 2019-04-16 2020-10-22 Celagenex Research (India) Pvt. Ltd. Synergistic lipid controlling compositions
CN113081989B (zh) * 2021-03-29 2022-10-21 海南普利制药股份有限公司 别嘌醇缓释片剂
CN113861347A (zh) * 2021-11-02 2021-12-31 南京信息工程大学 改性环糊精高分子缓释薄荷香型材料及制备方法和应用
CN114588123B (zh) * 2022-04-13 2023-12-22 苏州中化药品工业有限公司 一种高稳定性盐酸西替利嗪片剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0624903A (ja) * 1992-04-09 1994-02-01 Nippon Bayeragrochem Kk 植物処理剤
DE4446470A1 (de) * 1994-12-23 1996-06-27 Basf Ag Verfahren zur Herstellung von teilbaren Tabletten
EP0862463A1 (en) * 1995-11-23 1998-09-09 Janssen Pharmaceutica N.V. Solid mixtures of cyclodextrins prepared via melt-extrusion

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006089993A2 (es) 2005-02-25 2006-08-31 Universidade De Santiago De Compostela Procedimiento de obtención de hidrogeles de ciclodextrinas con glicidiléteres, las composiciones obtenidas y sus aplicaciones

Also Published As

Publication number Publication date
BR0008872B1 (pt) 2011-05-17
EP1158962A1 (de) 2001-12-05
ATE228828T1 (de) 2002-12-15
DK1158962T3 (da) 2003-01-06
DE19911097A1 (de) 2000-09-14
JP2002539151A (ja) 2002-11-19
PT1158962E (pt) 2003-04-30
CA2367020A1 (en) 2000-09-21
DE50000866D1 (de) 2003-01-16
WO2000054751A1 (de) 2000-09-21
CA2367020C (en) 2008-12-16
EP1158962B1 (de) 2002-12-04
JP4861552B2 (ja) 2012-01-25
BR0008872A (pt) 2002-01-02

Similar Documents

Publication Publication Date Title
ES2187457T3 (es) Procedimiento para la obtencion de formas de dosificacion solidas que contienen ciclodextrina.
WO2004078797A8 (en) Macromolecular ketoaldehydes
WO1998010752A3 (de) Verfahren zur herstellung fester pharmazeutischer formen durch extrudierung
DK1284716T3 (da) Selvemulgerende aktivstofformulering og anvendelse af denne formulering
BR0114558B1 (pt) processo para a preparaÇço de um material de espuma polimÉrico e espuma polimÉrica.
BR0014446A (pt) Composições catalisadoras organometais
BR0208126A (pt) Conjugados de ingrediente ativo de has
WO2002100382A3 (en) Controlled release dosage forms using acrylic polymer, and process for making the same
BRPI0409185A (pt) formulações veterinárias anti-helmìnticas tópicas
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
BR0309340A (pt) Materiais, sua preparação e uso
BR0111257A (pt) Formulação, e, uso de uma formulação
WO2001045678A3 (de) Arzneimittel, verfahren zu dessen herstellung und dessen verwendung
EA200200387A1 (ru) Сердцевина таблетки, изготовленная из полимера способом прямого прессования
BR0213276A (pt) Método de colagem de materiais a base de madeira
DE60117651D1 (de) Bioabbaubare Zusammensetzung und Verfahren zur deren Herstellung
ATE315596T1 (de) Verfahren zur herstellung kautschukhaltiger thermoplastischer formmassen
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
ES2165061T3 (es) Derivados de 4-aralquilaminopirimidina biciclicos utilizados como inhibidores de la tirosina kinasa.
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
WO2003063824A3 (en) Pharmaceutical composition
ATE266388T1 (de) Verfahren zur herstellung von formulierungen zur direkttablettierung
ATE387089T1 (de) Granulatförmige zusammensetzungen und verfahren zu ihrer herstellung
BR0115359A (pt) Método para a preparação de uma composição catalisadora e seu uso em um processo de polimerização
BR0008739A (pt) Composições de liberação controlada debeta-histina